TrialActa dermato-venereologica2024

Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin According to the Investigator's Global Assessment: A Post Hoc Analysis of a Phase 3 Trial.

Michael J Cork et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.